Your browser doesn't support javascript.
loading
The JAK1/2 inhibitor ruxolitinib downregulates the immune checkpoint protein B7H3 in multiple myeloma.
Xu, Ning; Yu, Erin; Ng, Nicole; Li, Mingjie; Bujarski, Sean; Hekmati, Ava; Nassir, Isabella; Hekmati, Tara; Yu, Janna; Daniely, David; Wang, Cathy S; Kim, Clara; Chen, Haiming; Berenson, James R.
Afiliación
  • Xu N; Institute for Myeloma & Bone Cancer Research, West Hollywood, California, USA.
  • Yu E; Institute for Myeloma & Bone Cancer Research, West Hollywood, California, USA.
  • Ng N; Institute for Myeloma & Bone Cancer Research, West Hollywood, California, USA.
  • Li M; Institute for Myeloma & Bone Cancer Research, West Hollywood, California, USA.
  • Bujarski S; James R. Berenson, MD, Inc, Berenson Cancer Center, West Hollywood, California, USA.
  • Hekmati A; Institute for Myeloma & Bone Cancer Research, West Hollywood, California, USA.
  • Nassir I; Institute for Myeloma & Bone Cancer Research, West Hollywood, California, USA.
  • Hekmati T; Institute for Myeloma & Bone Cancer Research, West Hollywood, California, USA.
  • Yu J; Institute for Myeloma & Bone Cancer Research, West Hollywood, California, USA.
  • Daniely D; Institute for Myeloma & Bone Cancer Research, West Hollywood, California, USA.
  • Wang CS; Institute for Myeloma & Bone Cancer Research, West Hollywood, California, USA.
  • Kim C; Oncotherapeutics, West Hollywood, California, USA.
  • Chen H; Institute for Myeloma & Bone Cancer Research, West Hollywood, California, USA.
  • Berenson JR; Institute for Myeloma & Bone Cancer Research, West Hollywood, California, USA.
Hematol Oncol ; 41(3): 578-582, 2023 Aug.
Article en En | MEDLINE | ID: mdl-36043430

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans Idioma: En Revista: Hematol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans Idioma: En Revista: Hematol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
...